A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
This study has been completed.
First Posted: November 6, 2008
Last Update Posted: December 28, 2015
Information provided by (Responsible Party):